Newborn Screening for SCID Identifies Patients with Ataxia Telangiectasia

[1]  J. Casanova,et al.  Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015 , 2015, Journal of Clinical Immunology.

[2]  H. Ochs,et al.  Primary immunodeficiency diseases : a molecular and genetic approach , 2013 .

[3]  Janaka N. Edirisinghe,et al.  Vitamin K2 Is a Mitochondrial Electron Carrier That Rescues Pink1 Deficiency , 2012, Science.

[4]  U. Sack,et al.  Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. , 2012, Blood.

[5]  E. Coustan-Smith,et al.  Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K , 2012, The Journal of experimental medicine.

[6]  A. Broeks,et al.  Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia‐telangiectasia: A genotype–phenotype study , 2012, Human mutation.

[7]  J. Verbsky,et al.  The Wisconsin approach to newborn screening for severe combined immunodeficiency. , 2012, The Journal of allergy and clinical immunology.

[8]  R. Buckley.  The long quest for neonatal screening for severe combined immunodeficiency. , 2012, The Journal of allergy and clinical immunology.

[9]  K. Herrup,et al.  Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia-telangiectasia , 2012, Nature Medicine.

[10]  J. Puck.  Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles. , 2012, The Journal of allergy and clinical immunology.

[11]  T. Morio,et al.  Functional characterization and targeted correction of ATM mutations identified in Japanese patients with ataxia‐telangiectasia , 2012, Human mutation.

[12]  G. Stewart,et al.  Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia , 2011, British Journal of Cancer.

[13]  Gonçalo R. Abecasis,et al.  The variant call format and VCFtools , 2011, Bioinform..

[14]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[15]  F. Rieux-Laucat,et al.  Whole-exome-sequencing-based discovery of human FADD deficiency. , 2010, American journal of human genetics.

[16]  J. Casanova,et al.  Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma , 2010, The Journal of experimental medicine.

[17]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[18]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[19]  Michael Brudno,et al.  Savant: genome browser for high-throughput sequencing data , 2010, Bioinform..

[20]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[21]  C. Dvorak,et al.  Radiosensitive severe combined immunodeficiency disease. , 2010, Immunology and allergy clinics of North America.

[22]  R. Laessig,et al.  Statewide newborn screening for severe T-cell lymphopenia. , 2009, JAMA.

[23]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[24]  R. Schiestl,et al.  Experimental Antioxidant Therapy in Ataxia Telangiectasia , 2008, Clinical medicine. Oncology.

[25]  A. Børresen-Dale,et al.  Alpha fetoprotein is increasing with age in ataxia-telangiectasia. , 2007, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[26]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[27]  J. Puck.  Population-based newborn screening for severe combined immunodeficiency: steps toward implementation. , 2007, The Journal of allergy and clinical immunology.

[28]  Shigeaki Nonoyama,et al.  Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. , 2007, The Journal of allergy and clinical immunology.

[29]  B. Rost,et al.  SNAP: predict effect of non-synonymous polymorphisms on function , 2007, Nucleic acids research.

[30]  Nazneen Rahman,et al.  ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles , 2006, Nature Genetics.

[31]  J. Puck,et al.  A novel IL2RG mutation associated with maternal T lymphocyte engraftment in a patient with severe combined immunodeficiency , 2006, Journal of Human Genetics.

[32]  J. Puck,et al.  Development of population-based newborn screening for severe combined immunodeficiency. , 2005, The Journal of allergy and clinical immunology.

[33]  R. Buckley.  The multiple causes of human SCID. , 2004, The Journal of clinical investigation.

[34]  F. Gumy-Pause,et al.  ATM gene and lymphoid malignancies , 2004, Leukemia.

[35]  J. Gerberding,et al.  Morbidity and Mortality Weekly Report Inside: Continuing Education Examination Applying Public Health Strategies to Primary Immunodeficiency Diseases a Potential Approach to Genetic Disorders Centers for Disease Control and Prevention Epidemiology Program Office Recommendations and Reports 1 Applyin , 2022 .

[36]  P. Oefner,et al.  Contributions of ATM mutations to familial breast and ovarian cancer. , 2003, Cancer research.

[37]  R. A. Zimmerman,et al.  Ataxia-telangiectasia: the pattern of cerebellar atrophy on MRI , 2003, Neuroradiology.

[38]  J. Puck,et al.  Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. , 2002, Blood.

[39]  R. Collins,et al.  Assessment of thymic output in adults after haematopoietic stemcell transplantation and prediction of T-cell reconstitution , 2000, The Lancet.

[40]  U. Göbel,et al.  Alpha1-Fetoprotein (AFP) Reference Values in Infants up to 2 Years of Age , 1998 .

[41]  D Morrell,et al.  Incidence of cancer in 161 families affected by ataxia-telangiectasia. , 1991, The New England journal of medicine.

[42]  A. Taylor,et al.  Unusual features in the inheritance of ataxia telangiectasia , 1990, Human Genetics.

[43]  M. Skolnick,et al.  The incidence and gene frequency of ataxia-telangiectasia in the United States. , 1986, American journal of human genetics.

[44]  N. Gueven,et al.  Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia. , 2007, British medical bulletin.

[45]  T. Dörk,et al.  Characterization of ATM gene mutations in 66 ataxia telangiectasia families. , 1999, Human molecular genetics.

[46]  U. Göbel,et al.  Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age. , 1998, Pediatric hematology and oncology.

[47]  E. Boder,et al.  Ataxia-telangiectasia. (Clinical and immunological aspects). , 1970, Psychiatrie, Neurologie und medizinische Psychologie. Beihefte.